Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. - Wikidata - wikimedia - TriplyDB

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients.

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients.

http://www.wikidata.org/entity/Q43036202

about

Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C.Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy.Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome Clinical guidelines on the management of hepatitis C Viral Determinants of Resistance to Treatment in Patients with Hepatitis C Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region Quasispecies of genotype 4 of hepatitis C virus genomes in Saudi patients managed with interferon alfa and ribavirin therapy Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection.Hepatitis C virus and alcohol.Structural analysis of hepatitis C RNA genome using DNA microarrays Molecular biology and clinical implication of hepatitis C virus.Intrinsic Viral Factors Are the Dominant Determinants of the Hepatitis C Virus Response to Interferon Alpha Treatment in Chimeric Mice.Is laparoscopy an advantage in the diagnosis of cirrhosis in chronic hepatitis C virus infection?The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3.High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy.Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C.Treatment with recombinant interferon-alpha 2a for patients with chronic hepatitis C: predictive factors for biochemical and virologic response. Osaka Liver Disease Study Group.Sequence variation of the hypervariable region in HCV carriers with normal ALT levels: a comparison with symptomatic carriers.High levels of serum interleukin-10 are associated with a poor response to interferon treatment in patients with chronic hepatitis C.Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation.Non-isotopic detection of hepatitis C virus quasispecies by single strand conformation polymorphism.Review article: interferon and hepatitis C--factors predicting therapeutic outcome.Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients.Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon].Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C.Decreased diversity of hepatitis C virus quasispecies during bone marrow transplantation.Effect of increasing dose of interferon on the evolution of hepatitis C virus 1b quasispecies.Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: a prospective study.Hypervariable region 1 of hepatitis C virus genome and response to interferon therapy.Influence of three successive antiviral treatments on viral heterogeneity in nonresponder chronic hepatitis C patients.Factors predictive of response to interferon-alpha therapy in hepatitis C virus type 1b infection.Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-alpha.Significance of serum soluble Fas antigen level in chronic hepatitis C patients treated with interferon: relationship to the therapeutic response.

P2860

Q27469364-F4904562-7CFD-46B9-923A-4581AC0CEB0F Q27469549-44C57440-DF4C-436E-A552-A788F9FF56FF Q27469620-6397E9AC-76E9-4EC3-BF60-570C6E90E4AF Q27471683-D2987C73-2B1C-4102-B9C0-F226C6F626EC Q27477946-33DED71A-D1CF-48EA-B63F-B466799A00CF Q27478062-B5D3C106-6135-4475-9F94-AA78E8F03B73 Q27478292-71B74F45-CE1A-47F6-96E8-DF0BAF9BD8B2 Q33791250-90F6BB18-66DC-4BE0-951F-841C8A709E8C Q33834509-915E1956-4952-4F3D-B044-B67200461B05 Q33944512-C5B4DF6B-B4A9-4C0D-87FD-B4E859C34901 Q35618748-8F3BF247-F3A2-4665-B41B-0BBDCE596D13 Q35755597-D478CCA1-68DC-432D-BC9D-AE71DD66CF7E Q35893868-FC0F7A47-58CE-47B4-9D56-BCB04A91E810 Q36178685-1D94379A-0F2B-4123-B9DF-275007BFCD99 Q40881380-BC188416-7DC0-46B4-B429-1FF8927DD6E0 Q42661814-A6309234-0166-408A-809C-9F4FB01A5936 Q42978762-E0EDF397-0A0F-4CA9-839F-80BB0DDA6B61 Q42979897-76073C2A-6363-43A4-90C9-E1FCE4FC8296 Q42981110-05DDDABB-D4BF-4D4E-B922-2AD08B849F20 Q42981662-6701F63D-285B-4FD9-9446-32BD981AD943 Q42985123-E5387F4E-599B-403C-B95A-B1AB885EF04A Q42985458-BE285824-75F7-4ED1-B5BB-109B18713744 Q42989240-BCCEE852-696C-43F5-93CA-F25194FE1F41 Q42990500-CCEFD24E-D78B-4D01-8CFC-7C9707F7A019 Q42992257-C33F93C1-D0A4-4064-8723-F2726D4D3764 Q42993278-B88F9B50-4704-439C-947D-969E0DE2FCD8 Q42993589-5264B0A6-9DA7-4B87-8A75-DA93CFA7C8FB Q42996442-EC7F6569-D54F-443F-8CB5-752FB4A5C79A Q42997745-A8F6FFFB-1FE9-42D5-A5F8-4A4ADBF0557F Q43001179-E9EC1960-4D56-4BCC-B9F2-BBF3C2589744 Q43035657-2455F2A5-EDBA-4DE1-8B82-0CC976C60D24 Q43036691-8E96B4FB-3895-43C2-AB16-9EACB7C1058D Q43039761-0FD4BC34-5200-43C4-8316-E06EF99E2D37 Q43762369-D21CDAEC-9E2E-4FBC-9588-F684E15438C0

P2860

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients.

http://www.wikidata.org/entity/Q43036202

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年学术文章

@wuu

1994年学术文章

@zh

1994年学术文章

@zh-cn

1994年学术文章

@zh-hans

1994年学术文章

@zh-my

1994年学术文章

@zh-sg

1994年學術文章

@yue

1994年學術文章

@zh-hant

name

Influence of viral quasispecie ...... chronic hepatitis C patients.

@en

Influence of viral quasispecie ...... chronic hepatitis C patients.

@nl

type

label

Influence of viral quasispecie ...... chronic hepatitis C patients.

@en

Influence of viral quasispecie ...... chronic hepatitis C patients.

@nl

prefLabel

Influence of viral quasispecie ...... chronic hepatitis C patients.

@en

Influence of viral quasispecie ...... chronic hepatitis C patients.

@nl

P1433

Q43036202-9C951403-7052-4EA0-B85D-1C90ECF047DC

P1476

Q43036202-35A0A1DB-3BD5-4AF8-8748-A2B4E0D713D7

P2093

Q43036202-024D335F-690F-4BAE-BBC8-578E025A8159

Q43036202-02BFCA80-99E2-4AE8-B09E-E8FD23E0EA1B

Q43036202-1771A31A-96A1-45AF-9127-DABB1527C820

Q43036202-25C0086C-CCE6-48E1-AB4F-CC8B999B68AA

Q43036202-3541933A-4772-474B-8841-DEEB801BB9C4

Q43036202-35B225BA-672A-44B6-95E0-A90CEA84C9BD

Q43036202-9F0EB283-E9F8-4A15-8D0B-695753A0DC1C

Q43036202-AEA3012D-95AF-473A-A439-FE7D136EBC2E

P304

Q43036202-7C797133-FFF2-4B44-85BC-A171F31A1950

P31

Q43036202-5C662577-82DD-426D-B258-B52617592AF9

P356

Q43036202-3F3CAF9F-DEC6-4D71-80AE-C3FC9F9F2E9A

P407

Q43036202-86C6C3B7-3D2D-4941-B1C3-0BB0A1F04830

P433

Q43036202-D1509849-60ED-46A0-A2C6-14329CAC6CE2

P478

Q43036202-376F8A55-BD19-4471-A9A8-257183C2001E

P577

Q43036202-283157C9-C9C9-4B45-9930-5542AA48C645

P698

Q43036202-2C7E1C9B-5E5F-4BF3-B601-20E73563CB40

P356

P1433

P1476

Influence of viral quasispecie ...... chronic hepatitis C patients.

@en

P2093

Fusamoto H

http://www.w3.org/2001/XMLSchema#string

Hagiwara H

http://www.w3.org/2001/XMLSchema#string

Hayashi N

http://www.w3.org/2001/XMLSchema#string

Kamada T

http://www.w3.org/2001/XMLSchema#string

Kanazawa Y

http://www.w3.org/2001/XMLSchema#string

Kasahara A

http://www.w3.org/2001/XMLSchema#string

Li T

http://www.w3.org/2001/XMLSchema#string

Mita E

http://www.w3.org/2001/XMLSchema#string

P304

1121-1130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.1840200504

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

1994-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7523271

http://www.w3.org/2001/XMLSchema#string